Inactive Instrument

Highlights GW Pharmaceuticals plc

Equities

GWPH

US36197T1034

Highlights

Unlock all the news: Be the first to know and act before the market!

Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	13/21/13	RE
Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures	10/21/10	MT
Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	10/21/10	CI
Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy	17/21/17	MT
Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase	17/21/17	MT
Palla Pharma : Names New CEO; Shares Soar 18%	26/21/26	MT
Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals	05/21/05	MT
Jazz Pharmaceuticals plc completed the acquisition of GW Pharmaceuticals plc.	05/21/05	CI
Gw Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2021	03/21/03	CI
GW Pharmaceuticals : Shareholders' Green-light $7.2 Billion Sale To Jazz Pharmaceuticals	26/21/26	MT
GW Pharmaceuticals : Shareholders OK Takeover by Jazz Pharmaceuticals	24/21/24	MT
GW Pharmaceuticals plc Receives European Commission Approval for EPIDYOLEX® (Cannabidiol) for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	20/21/20	CI
Takeda Pharmaceutical : buys epilepsy treatment rights from Ovid for up to $856 million	03/21/03	RE
GW Pharmaceuticals : Receives Positive Opinion for Epidyolex Application in EU	26/21/26	MT
GW Pharmaceuticals plc Receives Positive CHMP Opinion for Epidyolex (Cannabidiol) for Use as Treatment of Seizures Associated with Tuberous Sclerosis Complex	26/21/26	CI
GW Pharmaceuticals : Reports Wider Q4 Losses, Higher Revenue	16/21/16	MT
GW Pharmaceuticals : Earnings Flash (GWPH) GW PHARMACEUTICALS Reports Q4 Revenue $148.2M	16/21/16	MT
GW Pharmaceuticals : Earnings Flash (GWPH) GW PHARMACEUTICALS Posts Q4 EPS $-0.08	16/21/16	MT
Gw Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	16/21/16	CI
GW Pharmaceuticals : Medical cannabis company Northern Leaf eyes London listing later this year	12/21/12	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GW Pharmaceuticals plc

Equities

GWPH

US36197T1034

Highlights

Filters